Clinic Waiting Room-based Study of Swahili Language Artificial Intelligence-driven Symptom Assessments in Tanzanian Primary Health Care Facilities

NCT04958577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2022-05-17

No results posted yet for this study

Summary

This study will evaluate the accuracy of the condition suggestions and urgency advice of the Swahili language Ada symptom assessment application (SAA), when symptoms are input by a lay-person user and a medical professional; these SAA results will then be compared to the condition suggestions and urgency advice of different tiers of doctors and a "gold standard" created by a panel.

Conditions

  • Abdominal Pain/Gastrointestinal Issues
  • Lower Respiratory System Conditions
  • Upper Respiratory System Conditions
  • Mental Health Conditions
  • Ophthalmology Conditions
  • Orthopedic Conditions
  • Cardiovascular System Conditions
  • Genitourinary System Conditions
  • ENT Conditions
  • Dermatology Conditions
  • Gynecology/Obstetrics Conditions
  • Neurological Conditions

Interventions

DEVICE

Ada Waiting Room App (WRA) and Ada Diagnostic Support Application (HDA)

This device is a medical device but will be used only observationally--this device takes a patient's symptoms into account by asking questions and gives a ranked list of likely conditions that the patient might have based on the answers to these questions. The assessment report also includes urgency advice levels, that is, which care the patient should proceed to based on the condition suggestions. The WRA is used by the patient directly and the HDA is used by the doctor to ask the questions to the patient.

Sponsors & Collaborators

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER
  • Ada Health GmbH

    lead INDUSTRY

Eligibility

Min Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-03
Primary Completion
2021-12-17
Completion
2022-06-01

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04958577 on ClinicalTrials.gov